Medicine
Photobiomodulation Therapy for Diabetic Wound Healing
Quick fact
Photobiomodulation was accidentally discovered in the 1960s, and today, specific wavelengths like 660 nm (red) and 810 nm (near-infrared) are used to stimulate tissue repair.
Why this is interesting
Imagine a small handheld light, not a surgery, that could help stubborn diabetic wounds finally close. How can shining red light on the skin actually speed up healing?
Read the full explanation
Understanding Photobiomodulation Therapy for Diabetic Wound Healing
Diabetic wounds often fail to heal because the body's natural repair processes are impaired. High blood sugar damages blood vessels and nerves, reducing blood flow and sensation, and creating a chronic inflammatory environment. Photobiomodulation therapy (PBM) involves applying low-intensity red or near-infrared light to the wound area. This light penetrates the skin and is absorbed by cells, particularly the mitochondria—the cell's energy producers. The absorbed light energy is converted into biological signals that boost the cells' energy production (ATP), helping them function better. As a result, cells involved in wound healing (like fibroblasts that make collagen, and immune cells) become more active and efficient. This process helps reduce inflammation, encourages the growth of new blood vessels (angiogenesis), and ultimately accelerates the closure of the wound. PBM is non-invasive, painless, and has very few side effects, making it gentle. However, it isn't a standalone cure; it works as an adjunct to standard care, such as keeping the wound clean, removing dead tissue, controlling blood sugar, and offloading pressure. In practice, a device is placed over the wound for several minutes, a few times per week, delivering a specific dose of light energy.
A deeper explanation
The mechanism begins with the absorption of photons by cytochrome c oxidase in the mitochondrial electron transport chain. This enzyme is a key player in oxidative phosphorylation. By providing light energy to cytochrome c oxidase, PBM enhances its activity, leading to increased electron transport and more efficient ATP synthesis. Moreover, light absorption triggers a temporary increase in reactive oxygen species (ROS) at low levels, which act as signal molecules that activate transcription factors. One such factor is NF-κB, which promotes cell survival and anti-inflammatory responses. Another is HIF-1α, which stimulates the expression of vascular endothelial growth factor (VEGF), driving angiogenesis. Additionally, PBM modulates cytokine levels, reducing pro-inflammatory mediators like IL-1β and TNF-α while increasing anti-inflammatory cytokines. This shift lowers oxidative stress and chronic inflammation, breaking the feedback loop that hinders healing. Enhanced fibroblast proliferation and migration lead to improved collagen deposition and wound contraction. Consequently, the therapeutic effect is not from thermal heating but from photochemical changes inside cells, triggering a cascade of molecular events that accelerate tissue repair. This is why PBM is also called low-level light therapy (LLLT), emphasizing its photochemical action rather than thermal ablation.